Ceva Santé Reports the Acquisition of Scout Bio

Share this
Ceva Santé

Ceva Santé Reports the Acquisition of Scout Bio


  • Ceva Santé entered into a definitive agreement to acquire Scout Bio as a strategic step to enhance its innovative capabilities by gaining access to Scout’s key advancements along with a pipeline of monoclonal antibodies and gene therapies for the treatment of chronic diseases in pets
  • Scout Bio is an animal health company indulged in the business of developing therapies for pets. Following the acquisition, Ceva aims to further enhance its global biotechnology activities in the animal healthcare sector
  • Post acquisition, Ceva will maintain the relationship between Scout Bio and the GTP at the University of Pennsylvania, enabling them to work together to advance current initiatives and investigate new product development activities

Ref: Ceva Santé | Image: Ceva Santé

Related News:- Veterinary Pharmaceutical Solutions Reports the Acquisition of Diamond Animal Health

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Shivani Chandra

Shivani is a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She covers news related to Product approvals, clinical trial results, and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions